United States · Platforms & data · Investing.com

Piper Sandler reiterates Climb Bio stock rating after ASN data

Published by Investing.com · United States 2 h ago

Read the full article on Investing.com Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.investing.com)

Also worth reading

AbbVie submits etentamig BLA for multiple myeloma

The Motley Fool

Ford's Maverick Hybrid Sales Just Surged 60%. Here's Exactly Why Investors Should Care.

LXP Industrial Trust (NYSE:LXP) Issues Earnings Results

U.S. economy is gathering steam. This is the chief reason why.

Myro (MYRO) Price Prediction: 2025, 2026, 2030

Novartis Raises Guidance After Trial Setbacks Hit Profit